microbiome

MaaT Pharma Phase III microbiome trial hits endpoints as stock soar
Clinical Trials Arena
Thu, 01/9/25 - 11:05 am
MaaT Pharma
microbiome
clinical trials
MaaT013
MaaT Pharma eyes Phase II after early success in ALS microbiome trial
Clinical Trials Arena
Tue, 11/26/24 - 11:23 am
MaaT Pharma
ALS
clinical trials
microbiome
MaaT-033
Seres Therapeutics’ SER-155 Shows Promising Clinical Results
Tip Ranks
Thu, 09/12/24 - 07:26 pm
Seres Therapeutics
microbiome
clinical trials
SER-155
stem cell transplant
Seres, indebted and in need of cash, agrees to sell microbiome pill to Nestle
BioPharma Dive
Thu, 06/6/24 - 11:46 am
Seres Therapeutics
microbiome
Nestle
C. difficile
Ferring’s microbiome and gene therapy firsts take the company beyond reproductive health
Pharma Voice
Thu, 02/22/24 - 11:45 am
Ferring Pharmaceuticals
gene therapy
microbiome
bladder cancer
C. difficile
Microbiome-based treatment shows potential in graft-versus-host disease
Biopharma Reporter
Tue, 12/19/23 - 10:16 am
MaaT Pharma
microbiome
graft vs host disease
MaaT013
Beaten by placebo, Evelo seeks partner for once-lauded microbiome platform and programs
Fierce Biotech
Tue, 10/17/23 - 09:57 pm
Evelo Biosciences
microbiome
clinical trials
psoriasis
Viome, a microbiome startup, raises $86.5M, inks distribution deal with CVS
TechCrunch
Mon, 08/21/23 - 10:17 am
Viome
microbiome
CVS Health
Innovation in immuno-oncology: Leading companies in microbiota restoration therapy
Clinical Trials Arena
Mon, 05/8/23 - 10:37 am
immuno-oncology
microbiome
Solarea Bio Announces First Close of Series B Financing Round
BioSpace
Mon, 05/8/23 - 10:15 am
Solarea Bio
funding
microbiome
FDA approves first oral microbiome therapy Vowst
Fierce Pharma
Thu, 04/27/23 - 11:53 am
Seres Therapeutics
microbiome
Vowst
SER-109
C. difficile
FDA
The state of the oncology microbiome therapeutics pipeline at a glance
Clinical Trials Arena
Fri, 03/10/23 - 11:23 am
oncology
cancer
microbiome
drug development
Is MaaT back? After 18 months on hold, microbiome biotech sees end to impasse with FDA
Fierce Biotech
Fri, 02/3/23 - 10:55 am
MaaT Pharma
microbiome
FDA
fecal microbiome
MaaT013
Finch throws in the towel on microbiome journey, lets go of 77 employees
Endpoints
Tue, 01/24/23 - 10:23 am
Finch Therapeutics
layoffs
microbiome
This Week at FDA: FDA approves first FMT product, upcoming mpox guidance, and more
RAPS.org
Sun, 12/4/22 - 01:29 pm
FDA
regulatory
mpox
Ferring Pharmaceuticals
microbiome
COVID-19
Eli Lilly
FDA approves first fecal microbiome drug, setting stage for others
Stat
Thu, 12/1/22 - 10:41 am
Ferring Pharmaceuticals
Rebyota
FDA
C. difficile
fecal microbiome
microbiome
Concerto Biosciences Raises $23 Million in Series A to Advance Product Development, Expand Pipeline
BioSpace
Wed, 11/2/22 - 10:07 am
Concerto Biosciences
funding
microbiome
Seres one step closer to bringing first oral microbiome therapy to market as FDA mulls approval
Fierce Biotech
Wed, 10/26/22 - 10:51 am
Seres Therapeutics
microbiome
C. difficile
SER-109
Novome gets $43.5M boost for its engineered microbiome therapies
MedCity News
Tue, 09/13/22 - 08:01 pm
Novome Biotechnologies
funding
microbiome
Go or no go? Bristol’s Tyk2 test
EP Vantage
Wed, 08/31/22 - 10:15 am
FDA
Bristol Myers Squibb
deucravacitinib
Amylyx Pharmaceuticals
ALS
AMX0035
Ferring Pharmaceuticals
microbiome
RBX2660
Revance Therapeutics
Bluebird Bio
Spectrum Pharmaceuticals
JNJ
Oncopeptides

Pages